Loading...
XNAS
GRAL
Market cap1.39bUSD
Jun 03, Last price  
38.55USD
1D
2.80%
1Q
0.65%
IPO
126.76%
Name

Grail Inc

Chart & Performance

D1W1MN
P/E
P/S
11.04
EPS
Div Yield, %
Shrs. gr., 5y
-23.68%
Rev. gr., 5y
%
Revenues
126m
+34.90%
00014,612,00055,550,00093,105,000125,595,000
Net income
-2.03b
L+38.30%
-275,718,000-244,855,000-312,156,000-1,247,775,000-5,399,098,000-1,465,685,000-2,027,005,000
CFO
-577m
L-3.13%
-209,260,000-245,794,000-232,002,000-688,130,000-561,313,000-595,800,000-577,156,000

Profile

GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
IPO date
Jun 12, 2024
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122022‑002021‑122020‑122019‑122018‑12
Income
Revenues
125,595
34.90%
93,105
67.61%
55,550
280.17%
Cost of revenue
893,817
890,021
798,009
Unusual Expense (Income)
NOPBT
(768,222)
(796,916)
(742,459)
NOPBT Margin
Operating Taxes
(135,356)
(41,951)
(42,290)
Tax Rate
NOPAT
(632,866)
(754,965)
(700,169)
Net income
(2,027,005)
38.30%
(1,465,685)
-72.85%
(5,399,098)
332.70%
Dividends
Dividend yield
Proceeds from repurchase of equity
(234)
(4,183)
BB yield
Debt
Debt current
13,260
14,809
13,335
Long-term debt
123,022
154,005
165,350
Deferred revenue
Other long-term liabilities
2,236
1,498
3,134
Net debt
(627,188)
67,302
(67,443)
Cash flow
Cash from operating activities
(577,156)
(595,800)
(561,313)
CAPEX
(5,208)
(12,887)
(22,859)
Cash from investing activities
(551,011)
(12,887)
(22,859)
Cash from financing activities
1,244,300
463,766
604,817
FCF
(598,919)
(725,623)
(898,892)
Balance
Cash
763,470
97,287
241,596
Long term investments
4,225
4,532
Excess cash
757,190
96,857
243,350
Stockholders' equity
(9,801,845)
3,646,187
4,646,161
Invested Capital
12,375,627
4,278,348
4,501,954
ROIC
ROCE
EV
Common stock shares outstanding
31,901
31,053
31,053
Price
17.85
 
Market cap
569,437
 
EV
(57,751)
EBITDA
(610,166)
(638,219)
(587,696)
EV/EBITDA
0.09
Interest
Interest/NOPBT